| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/02/2009 | CA2699047A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699039A1 Use of bpp-b as a therapeutic agent |
| 04/02/2009 | CA2699035A1 Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent |
| 04/02/2009 | CA2699000A1 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide gly-arg-gly-asp-asn-pro-oh as a therapeutic agent |
| 04/02/2009 | CA2698775A1 Big gastrin i as a therapeutic agent |
| 04/02/2009 | CA2698772A1 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent |
| 04/02/2009 | CA2698768A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2698764A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2698762A1 Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agent |
| 04/02/2009 | CA2698751A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2698673A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2698672A1 Use of a peptide as a therapeutic agent |
| 04/01/2009 | EP2042503A1 Compound having acidic group which may be protected, and use thereof |
| 04/01/2009 | EP2042500A1 N-[4-(1-H-pyrazolo[3,4-c]pyridin-4-yl)phenyl]-N'-[(hetero)aryl]-urea compounds, pharmaceutical compositions comprising them, their preparation and their use as Tie2-kinase inhibitors |
| 04/01/2009 | EP2042494A1 2,4,5-trisubstituted thiazole compounds,preparation methods, pharmaceutical compositions and medical uses thereof |
| 04/01/2009 | EP2042195A1 Polymer conjugate of combretastatin |
| 04/01/2009 | EP2042190A1 Ameliorating agent for brain damage |
| 04/01/2009 | EP2042181A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
| 04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
| 04/01/2009 | EP2041144A1 Substituted benzoxepino-isoxazoles and use thereof |
| 04/01/2009 | EP2041104A1 Cinnamoyl-piperazine derivatives and their use as par- i antagonists |
| 04/01/2009 | EP2041100A1 Substituted 5- phenylamino- 1, 3, 4-oxadiaz0l-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase |
| 04/01/2009 | EP2041083A1 Zofenopril calcium |
| 04/01/2009 | EP2040758A2 Bioresponsive polymers |
| 04/01/2009 | EP2040732A1 New use of therapeutically useful peptides |
| 04/01/2009 | EP2040729A2 Attenuation of reperfusion injury |
| 04/01/2009 | EP2040691A1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoic acid |
| 04/01/2009 | EP2040673A2 Methods and compositions for treating post-myocardial infarction damage |
| 04/01/2009 | EP1924259A4 Inhibition of intermediate-conductance calcium activated potassium channels in the treatment and/or prevention of atherosclerosis |
| 04/01/2009 | EP1549341B1 Tissue factor targeted antibodies as anticoagulants |
| 04/01/2009 | EP1521744B1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 04/01/2009 | EP1294379B1 A new use for deferiprone |
| 04/01/2009 | EP1137666B9 Glp-1 analogues |
| 04/01/2009 | EP1126828B1 Oral administration of adenosine analogs |
| 04/01/2009 | CN101400703A Domain antibody construct |
| 04/01/2009 | CN101400659A Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 04/01/2009 | CN101400345A Cardioplegic solution |
| 04/01/2009 | CN101397551A Neukinase and its use in treatment of cardiovascular disease |
| 04/01/2009 | CN101397337A Neuroregulation protein mutant and uses thereof |
| 04/01/2009 | CN101397327A Method for preparing dihydro ginsenoside Rg2 and use thereof |
| 04/01/2009 | CN101397326A Ginsenoside Rb1 containing impurity ginsenoside Rg2 |
| 04/01/2009 | CN101397315A Tonka bean camphor glycosides compounds, preparation method thereof and medicament composition and use thereof |
| 04/01/2009 | CN101397298A Acidamide substituted pyrrole[2,3-b] pyridines compounds, preparation method and use thereof |
| 04/01/2009 | CN101397296A Levalfuzosin, preparation method and use thereof |
| 04/01/2009 | CN101397295A 2-dihydroindolemanone derivates as histone deacetylase inhibitor, preparation method and use thereof |
| 04/01/2009 | CN101397272A Method for preparing ozagrel sodium crystal |
| 04/01/2009 | CN101396562A Use of composition containing ARB in preparing medicine for treating hyperhomocysteinemia injury and related diseases thereof |
| 04/01/2009 | CN101396561A Use of composition containing ACEI in preparing medicine for treating hyperhomocysteinemia injury and related diseases thereof |
| 04/01/2009 | CN101396543A Pure traditional Chinese medicine preparation for treating cardio-cerebrovascular disease |
| 04/01/2009 | CN101396537A Chinese patent medicine capable of dredging collateral |
| 04/01/2009 | CN101396525A Traditional Chinese medicine preparation for treating cerebrovascular disease |
| 04/01/2009 | CN101396521A Use of traditional Chinese medicine composition in preparing medicine for treating cerebral circulation insufficiency |
| 04/01/2009 | CN101396519A Quality control method of pulse-invigorating and heart-nourishing pill |
| 04/01/2009 | CN101396516A Medicine for treating hypertension |
| 04/01/2009 | CN101396515A Medicine for treating hypertension and complication |
| 04/01/2009 | CN101396498A Traditional Chinese medicine preparation for treating cerebrovascular disease |
| 04/01/2009 | CN101396495A Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 04/01/2009 | CN101396468A Traditional Chinese medicine for treating diabetes coronary heart disease |
| 04/01/2009 | CN101396460A Preparation method of anti-hemorrhoid extract containing rutin and naringin |
| 04/01/2009 | CN101396459A Traditional Chinese medicine blood-pressure reduction tea for treating hypotension |
| 04/01/2009 | CN101396451A Preparation method of Naodesheng orally disintegrating tablets |
| 04/01/2009 | CN101396434A Method for separating total alkaloids from dactylicapnos root |
| 04/01/2009 | CN101396424A Medicine composition for treating and preventing the cardio-cerebrovascular disease and preparation method thereof |
| 04/01/2009 | CN101396388A Extraction method of Jumi extract and preparation method of the Jumi preparation |
| 04/01/2009 | CN101396387A Use of Jumi extract for preparing medicine for preventing and treating cardio-cerebrovascular disease |
| 04/01/2009 | CN101396366A Solid oral preparation containing valsartan and preparation method thereof |
| 04/01/2009 | CN101396358A Oxiracetam injection |
| 04/01/2009 | CN101396356A New use of bilobalide |
| 04/01/2009 | CN101396349A Pill for treating hemorrhoid |
| 04/01/2009 | CN101396344A Paeonol microemulsion preparation and preparation method thereof |
| 04/01/2009 | CN101396335A Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 04/01/2009 | CN101396334A Curcumin lipid carrier and preparation method thereof |
| 04/01/2009 | CN100473662C Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 04/01/2009 | CN100473415C Health-care product for treating cardiovascular and cerebralvascular disease |
| 04/01/2009 | CN100473404C Hypertension treating Chinese medicine preparation |
| 04/01/2009 | CN100473401C Chinese medicine preparation for preventing and treating cerebral thrombus and sequel thereof |
| 04/01/2009 | CN100473390C Method for preparing pharmaceutics of a single drug of japanese ginseng and general saponin thereof |
| 04/01/2009 | CN100473387C Calf serum de-protein injection and producing method thereof |
| 04/01/2009 | CN100473383C Pharmaceutical composition for promoting angiogenesis |
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511074 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke |
| 03/31/2009 | US7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/31/2009 | US7511065 Mixed lineage kinase modulators |
| 03/31/2009 | US7511053 Spiroazacyclic compounds as monoamine receptor modulators |
| 03/31/2009 | US7511036 2-hydroxy-5,6-dimethyl-2-phenyl-2,3-dihydro-(1, 4)-thiazine-4-carbaldehyde; converted under acidic conditions to thiazolium agents that can prevent advanced glycated end products (AGEs) crosslink formation; hypotensive agent; reduced vascular compliance, diastolic dysfunction and heart failure |
| 03/31/2009 | US7511031 Transcutaneous photodynamic therapy; patch placed over target tissue; liposomal, transdermal, iontophoretic photosensitizing agent; light emitting diodes; atherosclerotic lesions and restenotic lesions |
| 03/31/2009 | US7511024 Factor VII or VIIA-like molecules |
| 03/31/2009 | US7511019 Method for treating a human patient for coronary artery disease, comprising administering into one or more coronary vessels in a human patient in need of treatment for coronary artery disease an effective amount of a recombinant fibroblast |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510728 Solid preparations |
| 03/31/2009 | US7510700 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 03/31/2009 | CA2448602C Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 03/31/2009 | CA2396734C Extraction of flavonoids |
| 03/31/2009 | CA2337175C Treatment of restenosis |
| 03/26/2009 | WO2009038681A1 Thiazolidinedione analogues for the treatment of hypertension |
| 03/26/2009 | WO2009038157A1 2,3-dihydroiminoisoindole derivative |
| 03/26/2009 | WO2009038064A1 Heterocyclic derivative having inhibitory activity on type-i 11β-hydroxysteroid dehydrogenase |